Impact of prior interventional treatment on the complications after Frey procedure for chronic pancreatitis.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 08 05 2019
accepted: 03 10 2019
pubmed: 28 10 2019
medline: 12 9 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

Chronic pancreatitis is an inflammatory disease responsible for pain partially explained by pancreatic duct dilatation. Early surgery has become the treatment of choice for hypertrophic pancreatic head with main pancreatic duct dilatation. Frey procedure (FP), combining both surgical resection and decompression, is one of the standard surgical procedures. However, a "step-up approach" with endoscopic or limited surgical procedures is still frequently proposed before referring to expert pancreatic centres. The aim of the study was to evaluate the impact of a prior treatment on post-operative complications of FP. All 61 consecutive patients who underwent FP between 2006 and 2017 were included. Perioperative data and outcomes were analyzed and compared according to the presence of a prior treatment. Twenty-four patients did not receive any prior treatment and thirty-seven patients had a prior endoscopic or limited surgical treatment. Preoperative data and outcomes were similar between the 2 groups. The rate of biliary derivation during FP was significantly higher in the group without prior endoscopic procedure. A prior treatment was not a risk factor for major morbidity (Clavien grade ≥ III). A first attempt of endoscopic or limited surgical procedures before FP may not influence post-operative complications. Even if not recommended, a "step-up approach" proposing a first less invasive treatment could still be proposed to the patients who want to delay a morbid surgical procedure.

Identifiants

pubmed: 31654115
doi: 10.1007/s00423-019-01832-8
pii: 10.1007/s00423-019-01832-8
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-830

Références

HPB (Oxford). 2017 Nov;19(11):978-985
pubmed: 28821411
BMC Gastroenterol. 2013 Mar 18;13:49
pubmed: 23506415
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
Medicine (Baltimore). 2018 May;97(19):e0651
pubmed: 29742705
Surgery. 2007 Jul;142(1):20-5
pubmed: 17629996
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Br J Surg. 2010 Jul;97(7):1087-95
pubmed: 20632276
Dig Surg. 2013;30(1):35-50
pubmed: 23635532
Arch Surg. 2012 Oct;147(10):925-32
pubmed: 23117832
J Gastrointest Surg. 2014 Oct;18(10):1863-9
pubmed: 24944153
Pancreatology. 2015 Jul-Aug;15(4):372-9
pubmed: 26055537
Clin Gastroenterol Hepatol. 2007 Nov;5(11):1354-65
pubmed: 17981248
Surg Today. 2018 Jan;48(1):58-65
pubmed: 28597350
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
Pancreas. 1987;2(6):701-7
pubmed: 3438308
Pancreatology. 2016 Jan-Feb;16(1):83-94
pubmed: 26620965
Cochrane Database Syst Rev. 2015 Mar 19;(3):CD007884
pubmed: 25790326
Pancreas. 2015 Jul;44(5):819-23
pubmed: 25882695
Am J Gastroenterol. 2007 Aug;102(8):1781-8
pubmed: 17509029
Lancet. 2011 Apr 2;377(9772):1184-97
pubmed: 21397320
Int J Surg. 2009 Aug;7(4):305-12
pubmed: 19501199

Auteurs

A Merdrignac (A)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

D Bergeat (D)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

F Robin (F)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

E Gaignard (E)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

K Turner (K)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

M Rayar (M)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.
INSERM 1414, CIC, Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

B Meunier (B)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

K Boudjema (K)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.
INSERM 1414, CIC, Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

Laurent Sulpice (L)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, INSERM 1241, NuMeCan (Nutrition Metabolism and Cancer), Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France. laurent.sulpice@chu-rennes.fr.
INSERM 1414, CIC, Université de Rennes 1, 2 rue Henri Le Guilloux, F-35000, Rennes, France. laurent.sulpice@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH